Diamond Packaging recently introduced new packaging designs to address the FDA-mandated over-the-counter (OTC) labeling requirements. Our new Design Relief® packaging features extended panels and pull-tab designs that maximize graphics without compromising shelf space.

The Food and Drug Administration’s new labeling, titled “Drug Facts”, will make it easier for consumers to understand information about a drug’s benefits, risks and proper usage and will impact all nonprescription drugs as well as drug-cosmetic products such as sunscreens. The FDA’s final ruling, first published in March 1999, requires drug companies to standardize presentation of information such as active ingredients, purpose, uses (indications), warnings, directions and other data in an easy to read format. Labeling must adhere to specific requirements for headings, subheadings and minimum type sizes.

Faced with the new labeling requirements demanding more space to convey drug information, companies are challenged to develop packaging that will still grab consumer’s attention in this ever-competitive marketplace. They understand the need to employ graphic elements that will give their products more shelf impact to stand apart from the competition.

Anticipating the need for additional text and improved graphics, Diamond Packaging developed Design Relief® cartons to deliver expanded surface area without significant changes in cost or carton size.

One such design features a foldout panel that is normally fastened to the carton exterior to promote brand identity and preserve billboard space, but can be easily opened by consumers to reveal compliance information. A second design incorporates a pull-tab panel that extends to reveal additional drug information or even promotional content such as coupons or brand cross marketing.

Both designs preserve room for product identity elements and logos, which are critical for consumer awareness and brand recognition.